Beta-Blocker — Migraine Prophylaxis
Pregnancy: Use with caution — associated with IUGR and neonatal bradycardia; monitor fetus if continued
Propranolol (Migraine Prevention)
Brand names: Inderal, Half-Inderal LA
Adult dose
Dose: 40–240 mg/day in divided doses or as modified-release once daily
Route: Oral
Frequency: Two to three times daily (IR); once daily (LA)
Max: 240 mg/day
First-line oral migraine prophylaxis — NICE recommended. Start 40 mg BD and titrate every 2 weeks. Half-Inderal LA 80 mg once daily is a convenient formulation. Minimum 2–3 month trial before assessing efficacy. Reduces migraine frequency by ~50% in responders.
Paediatric dose
Dose: 0.5–1 mg/day/kg
Route: Oral
Frequency: Two to three times daily
Max: 4 mg/kg/day
Children ≥12 years: 20–40 mg twice daily. Younger children: seek specialist opinion.
Dose adjustments
Renal
No specific dose adjustment required.
Hepatic
Caution — reduced first-pass metabolism in hepatic impairment; increased bioavailability.
Paediatric weight-based calculator
Children ≥12 years: 20–40 mg twice daily. Younger children: seek specialist opinion.
Clinical pearls
- MHRA: do NOT stop abruptly — rebound tachycardia, hypertension, and worsening migraine on withdrawal. Taper over 2–4 weeks.
- Useful dual-indication if patient has concurrent hypertension, anxiety, or essential tremor
- Contraindicated in asthma — single most important contraindication to remember. Use topiramate or amitriptyline as alternatives in asthmatics.
Contraindications
- Asthma or severe COPD
- Sinus bradycardia
- 2nd/3rd degree AV block
- Uncontrolled heart failure
- Phaeochromocytoma (without alpha-blockade)
- Raynaud's syndrome (relative)
Side effects
- Fatigue
- Cold extremities
- Bradycardia
- Bronchospasm (avoid in asthma)
- Sleep disturbance/nightmares
- Depression
- Erectile dysfunction
- Masking hypoglycaemia
Interactions
- Verapamil/diltiazem (severe bradycardia/AV block)
- Clonidine (rebound hypertension if propranolol stopped first)
- NSAIDs (reduce antihypertensive effect)
- Ergotamine (peripheral vasoconstriction — avoid combination in migraine)
Monitoring
- Migraine diary (frequency, duration, severity)
- Heart rate and blood pressure
- Peak flow if history of respiratory disease
Reference: BNFc; BNF 90; NICE NG218 (Migraine); BNFc. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Framingham Risk Score · Cardiovascular Risk
- Caprini Score for VTE Risk (2005) · VTE Risk
- SCORE2-Diabetes 10-Year CVD Risk in Type 2 Diabetes · Cardiovascular Risk
- PFO-Associated Stroke Causal Likelihood (PASCAL) Classification · Stroke Prevention
- PCP-HF Risk Score (Pooled Cohort Equations to Prevent Heart Failure) · Heart Failure Prevention
- CHADS-65 Score for Atrial Fibrillation · Atrial Fibrillation
Pathways
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Suspected Subarachnoid Haemorrhage · NICE NG228; RCEM 2023; AHA/ASA 2023
- Adult Head Injury · NICE NG232 (2023)
- Bell's Palsy / Facial Nerve Palsy · ENT UK 2017; AAN
- Vertigo Workup · ENT UK; NICE CKS